Pfizer reportedly aims to market OTC Lipitor after patent expires

Pfizer is considering launching a nonprescription form of blockbuster cholesterol-lowering drug Lipitor after a key patent expires in November, sources said. However, Pfizer is expected to have trouble doing so because of the FDA's concern that patients will misuse statins without medical guidance.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
San Jose, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA